Recent progress in therapeutic strategies and biomimetic nanomedicines for rheumatoid arthritis treatment

C Li, X Zheng, M Hu, M Jia, R Jin… - Expert opinion on drug …, 2022 - Taylor & Francis
Introduction Rheumatoid arthritis (RA) is an autoimmune systemic disease in which
inflammatory and immune cells accumulate in inflamed joints. Researchers aimed at the …

Re-directing nanomedicines to the spleen: A potential technology for peripheral immunomodulation

S Kaur, SM Allan, ZS Al-Ahmady - Journal of Controlled Release, 2022 - Elsevier
Modulation of peripheral immune cells in the spleen plays a key role in many life-threatening
conditions such as stroke. Immune cell changes can lead to the excessive release of pro …

Macrophage-targeted nanoparticle delivery systems

S Jain, M Amiji - … nanoparticles for drug delivery applications: imaging …, 2012 - Springer
Monocytes and macrophages originate from the mononuclear phagocyte system and form
the basis of immune defense system of the body. These cells are distributed throughout the …

[HTML][HTML] Update on nanoparticle-based drug delivery system for anti-inflammatory treatment

H Wang, Y Zhou, Q Sun, C Zhou, S Hu… - … in Bioengineering and …, 2021 - frontiersin.org
Nanobiotechnology plays an important role in drug delivery, and various kinds of
nanoparticles have demonstrated new properties, which may provide opportunities in …

[HTML][HTML] Macrophage-targeted nanomedicines for ARDS/ALI: Promise and potential

R Vichare, JM Janjic - Inflammation, 2022 - Springer
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are characterized by
progressive lung impairment typically triggered by inflammatory processes. The mortality toll …

Inflammation targeted nanomedicines: Patents and applications in cancer therapy

TK Praveen, HV Gangadharappa, ASA Lila… - Seminars in Cancer …, 2022 - Elsevier
Evident role of inflammation in cancer development and progression prompted the
application of anti-inflammatory medications as a therapeutic strategy. The major bottleneck …

Recent development of nanomedicine for the treatment of inflammatory diseases

M Higaki - Inflammation and Regeneration, 2009 - jstage.jst.go.jp
Nanotechnology carried out on the nanoscale-carriers has been developed for this two
decades. The delivery of pharmaceuticals can be improved by drug delivery systems (DDS) …

Nanoparticle-mediated drug delivery systems for the treatment of IBD: current perspectives

C Yang, D Merlin - International journal of nanomedicine, 2019 - Taylor & Francis
Inflammatory bowel disease (IBD), which mainly consists of Crohn's disease and ulcerative
colitis, is a chronic and relapsing inflammatory condition of the gastrointestinal tract. The …

[HTML][HTML] Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases

SK Patel, JM Janjic - Theranostics, 2015 - ncbi.nlm.nih.gov
Inflammatory disease management poses challenges due to the complexity of inflammation
and inherent patient variability, thereby necessitating patient-specific therapeutic …

“Zombie” Macrophages for Targeted Drug Delivery to Treat Acute Pneumonia

X Xu, CHT Kwong, J Li, J Wei… - ACS Applied Materials & …, 2023 - ACS Publications
A cell-based drug delivery system has emerged as a promising drug delivery platform. Due
to their innate inflammatory tropism, natural and engineered macrophages have exhibited …